Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernanda Maruri

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2016
Reversion of phenotypic fluoroquinolone resistance in Mycobacterium tuberculosisBrandon Eilertson, Fernanda Maruri, Amondrea Blackman, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolatesBrandon Eilertson, Fernanda Maruri, Amondrea Blackman, et al.
Microbiological Research|September 6, 2022
RNA editing in Mycobacterium tuberculosisYan Guo, Yuri F van der Heijden, Fernanda Maruri, et al.
The Journal of Infectious Diseases|April 20, 2023
Mycobacterium tuberculosis Gene Expression Associated With Fluoroquinolone Resistance and Efflux Pump InhibitionYuri F van der Heijden, Fernanda Maruri, Amondrea Blackman, et al.
BMC Research Notes|November 15, 2021
Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, PeruAlvaro Schwalb, Rodrigo Cachay, Ericka Meza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2020
Resistance-Conferring Mutations on Whole-Genome Sequencing of Fluoroquinolone-resistant and -Susceptible Mycobacterium tuberculosis Isolates: A Proposed Threshold for Identifying ResistanceFernanda Maruri, Yan Guo, Amondrea Blackman, et al.
The Journal of Antimicrobial Chemotherapy|June 5, 2016
A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosisBrandon Eilertson, Fernanda Maruri, Amondrea Blackman, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2012
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering systemFernanda Maruri, Timothy R Sterling, Anne W Kaiga, et al.
BMC Infectious Diseases|May 2, 2019
Increased vitamin D receptor expression from macrophages after stimulation with M. tuberculosis among persons who have recovered from extrapulmonary tuberculosisChristina T Fiske, Amondrea Blackman, Fernanda Maruri, et al.
The Journal of Antimicrobial Chemotherapy|March 31, 2009
Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistanceRose A Devasia, Amondrea Blackman, Carolyn May, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2016
Reversion of phenotypic fluoroquinolone resistance in Mycobacterium tuberculosisBrandon Eilertson, Fernanda Maruri, Amondrea Blackman, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolatesBrandon Eilertson, Fernanda Maruri, Amondrea Blackman, et al.
Microbiological Research|September 6, 2022
RNA editing in Mycobacterium tuberculosisYan Guo, Yuri F van der Heijden, Fernanda Maruri, et al.
The Journal of Infectious Diseases|April 20, 2023
Mycobacterium tuberculosis Gene Expression Associated With Fluoroquinolone Resistance and Efflux Pump InhibitionYuri F van der Heijden, Fernanda Maruri, Amondrea Blackman, et al.
BMC Research Notes|November 15, 2021
Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, PeruAlvaro Schwalb, Rodrigo Cachay, Ericka Meza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2020
Resistance-Conferring Mutations on Whole-Genome Sequencing of Fluoroquinolone-resistant and -Susceptible Mycobacterium tuberculosis Isolates: A Proposed Threshold for Identifying ResistanceFernanda Maruri, Yan Guo, Amondrea Blackman, et al.
The Journal of Antimicrobial Chemotherapy|June 5, 2016
A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosisBrandon Eilertson, Fernanda Maruri, Amondrea Blackman, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2012
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering systemFernanda Maruri, Timothy R Sterling, Anne W Kaiga, et al.
BMC Infectious Diseases|May 2, 2019
Increased vitamin D receptor expression from macrophages after stimulation with M. tuberculosis among persons who have recovered from extrapulmonary tuberculosisChristina T Fiske, Amondrea Blackman, Fernanda Maruri, et al.
The Journal of Antimicrobial Chemotherapy|March 31, 2009
Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistanceRose A Devasia, Amondrea Blackman, Carolyn May, et al.
Pageof 5